Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sunitinib and Capecitabine in First-Line Metastatic Colorectal Cancer
NCT00961571Phase 2Terminated
- Sponsor
- Georgetown University
- Start
- Aug 2009
- Primary completion
- Mar 2011
- Countries
- 1
01
Overview
A Phase 2 trial of sunitinib in metastatic colorectal cancer (mCRC), sponsored by Georgetown University. Started Aug 2009; status: terminated.
02
Drugs
sunitinib
03
Conditions
metastatic colorectal cancer (mCRC)
Beyond the preview
Go deeper on NCT00961571.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00961571.